SGLT2 Inhibitors for Diabetes May Protect Against AKI, Increase UTI Risk
Providers need to assess the benefit-risk profile of SGLT2 inhibitors for individual patients, and take steps to avoid unnecessary risks.
Diagnosis & Disease Information
Inappropriate Opioid, Gabapentinoid Prescribing in CKD Still a Problem
Opioid prescribing has declined in recent years, but nonetheless remains high for the chronic kidney disease population.
Allopurinol, Febuxostat Show Comparable Efficacy in Gout
The comparative efficacy of these therapies has been extended to patients with stage 3 chronic kidney disease, a common comorbidity in gout.
ICI-Based Urologic Cancer Therapies Tied to High Adverse Event Rates
Treatment-related adverse events of any grade develop in the majority of patients who receive urologic cancer therapies based on immune checkpoint inhibitors, according to a study.
Stopping RAAS Inhibitors Due to Hyperkalemia Leads to Adverse Outcomes in CKD
Findings from the observational study indicate that the benefits of continuing RAAS inhibitor use outweigh the risks in patients with nondialysis chronic kidney disease.
Cardiovascular Events, VTE Tied to Polycythemia During Testosterone Therapy
Testosterone therapy in the absence of polycythemia was not associated with an increased risk for major adverse cardiovascular events or venous thromboembolism.
SGLT2 Inhibitors Underprescribed for Chronic Kidney Disease
Affordability of SGLT2i may contribute to the low prescription rate in CKD.
Allopurinol Treatment Found Not to Increase Death Risk in CKD
This is the first study to assess the effect of allopurinol initiation on mortality in patients with CKD and concomitant gout, according to investigators.
Study Examines Prevalence of BP-Elevating Med Use in Patients With Hypertension
The researchers examined data from the National Health and Nutrition Examination Survey.
Most Immunosuppressive Meds Not Tied to Worse COVID-19 Outcomes
Except for rituximab, no increased risk seen for in-hospital death or mechanical ventilation for those on long-term immunosuppressive therapy
- Loading...
Loading...
Next post in Transplantation
Loading... 
Loading...